Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of OSI-906 in Combination With Pemetrexed in Advanced Solid Tumor Malignancies

NCT01567384 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT01567384
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01567384 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of OSI-906 in Combination With Pemetrexed in Advanced Solid Tumor Malignancies
Lead sponsor
Emory University
Phase
Phase 1
Overall status
Withdrawn
Start date
May 31, 2012
Completion date
October 31, 2013
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, neoplasms, tumors